| Patient | Benjamin Franklin |
|---|---|
| Date of birth | 1950-01-17 |
| Identifiers | MRN HR-EN004-SYN; SSN (made up) 000-04-3318 |
| Document date | 2026-07-06 |
| Author | Lydia Penhallow, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Hot, swollen left knee for two days. [S]
Mr. Franklin is a 76-year-old man with gout, stage 3a chronic kidney disease, and hypertension, seven weeks after his allopurinol was increased to 300 mg daily, who asked for a same-day visit. Two days ago, the morning after a long dinner with wine and roast meats, he woke with pain in the left knee, which has become hot and swollen and too painful to bend. He has never had gout in the knee; his earlier flares were in the right big toe. He takes colchicine 0.6 mg daily and has not missed doses. He has felt warm but has had no chills. He has had no injury, skin break, or recent procedure other than his prostate operation eleven weeks ago, and no urinary symptoms. He has taken acetaminophen, which barely helps, and no ibuprofen, as his kidney plan advises. [S]
| Element | Detail |
|---|---|
| Onset | Two days ago, on waking after a rich dinner with wine |
| Location | Left knee; first flare in this joint |
| Severity | Pain 8 of 10; cannot bend the knee or climb stairs |
| Current gout treatment | Allopurinol 300 mg daily for seven weeks; colchicine 0.6 mg daily without missed doses |
| Pertinent negatives | No injury, skin break, chills, or urinary symptoms |
| Modifying factors | Acetaminophen helps little; rest and ice help a little |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Feels warm; temperature 37.7 °C; no chills or rigors |
| Musculoskeletal | Positive | Painful, swollen left knee; no other joints affected; no back pain |
| Genitourinary | Negative | No dysuria, frequency, or blood in the urine since surgery |
| Integumentary | Negative | No wounds, rash, or insect bites over the knee |
| Gastrointestinal | Negative | No diarrhea on colchicine |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrochlorothiazide 25 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2019-05-06 to 2026-03-02 | stopped | S |
| Losartan 50 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-02 | active | S |
| Allopurinol 100 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-02 to 2026-03-30 | completed | S |
| Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth daily | Two tablets by mouth daily | Oral route | 2026-03-30 to 2026-05-18 | completed | S |
| Allopurinol 300 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-05-18 | active | S |
| Colchicine 0.6 mg oral tablet, one tablet by mouth daily for flare prophylaxis | One tablet by mouth daily | Oral route | 2026-03-02 to 2026-09-14 | completed | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth every 6 hours as needed for pain, no more than 3 g a day | Two tablets every 6 hours as needed; maximum 6 tablets a day | Oral route | 2026-03-02 | active | S |
| Tamsulosin 0.4 mg oral capsule, one capsule by mouth at bedtime until surgery | One capsule by mouth at bedtime | Oral route | 2026-03-30 to 2026-04-20 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-03-30 | active | S |
| Potassium citrate 10 mEq extended-release tablet, one tablet by mouth twice daily with meals | One tablet by mouth twice daily with meals | Oral route | 2026-05-18 | active | S |
| Prednisone 20 mg oral tablet, two tablets (40 mg) by mouth each morning for 5 days | Two tablets by mouth each morning for 5 days, with food | Oral route | 2026-07-06 to 2026-07-10 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-07-06 | Body height | 175 | cm | S |
| 2026-07-06 | Body weight | 94 | kg | S |
| 2026-07-06 | Body mass index (BMI) [Ratio] | 30.7 | kg/m2 | S |
| 2026-07-06 | Systolic blood pressure | 136 | mm[Hg] | S |
| 2026-07-06 | Diastolic blood pressure | 80 | mm[Hg] | S |
| 2026-07-06 | Heart rate | 84 | /min | S |
| 2026-07-06 | Respiratory rate | 16 | /min | S |
| 2026-07-06 | Body temperature | 37.7 | Cel | S |
| 2026-07-06 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-07-06 | Urate [Mass/volume] in Serum or Plasma | 5.9 | mg/dL | 3.5-7.2 mg/dL | Normal | S |
| 2026-07-06 | Potassium [Moles/volume] in Serum or Plasma | 4.7 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-07-06 | Creatinine [Mass/volume] in Serum or Plasma | 1.33 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-07-06 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 55 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Low | S |
| 2026-07-06 | Glucose [Mass/volume] in Serum or Plasma | 104 | mg/dL | 70-99 mg/dL | High | S |
Vital signs recorded on 2026-07-06; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Uncomfortable, walking with a stick; alert and talkative |
| Left knee | Large warm effusion with redness over the joint; range of motion 10 to 60 degrees, limited by pain; no skin break or cellulitis |
| Other joints | Right big toe, ankles, wrists, and hands normal; no tophi |
| Skin | No wounds or rash |
| Cardiovascular | Heart rate 84, regular |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Gout with recurrent flares, mostly in the right big toe, without tophi; synthetic modern diagnosis linked to his documented gout | active | confirmed | M1A.0710 | S — Synthetic modern diagnosis; his recurrent gout is documented in his own letters (D). |
| Bladder stone (2.6 cm, uric acid on analysis) with bladder outlet obstruction, removed by cystolitholapaxy; synthetic modern diagnosis linked to his documented stone | resolved | confirmed | N21.0 | S — Synthetic modern diagnosis confirmed by CT and cystoscopy; his stone is documented in his own letters (D), though its composition is not known. |
| Chronic kidney disease stage G3a A1 | active | confirmed | N18.31 | S — Synthetic diagnosis; no measure of kidney function from his lifetime exists. |
| Essential hypertension | active | confirmed | I10 | S — Synthetic diagnosis; no blood pressure from his lifetime exists. |
| Benign prostatic hyperplasia with lower urinary tract symptoms and bladder outlet obstruction, treated by transurethral resection | active | confirmed | N40.1 | S — Synthetic diagnosis made at the urology consultation as the probable cause of the bladder stone; the cause of his historical stone is not documented. |
| Acute gout flare of the left knee, crystal-proven, during urate-lowering titration; resolved | resolved | confirmed | M10.062 | S — Synthetic flare at an unscheduled visit; flares are common in the first months of urate-lowering therapy. It does not echo a dated historical attack. |
Guideline basis: 2020 American College of Rheumatology Guideline for the Management of Gout (2020); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, and benign prostatic hyperplasia monographs (2026)
Follow-up: Telephone call with the culture result in two days. Gout, kidney, and blood pressure review in September with a serum urate when he is free of the flare. Next scheduled visit 2026-09-14: gout, stone prevention, kidney, and blood pressure review at about six months. [S]